Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma.

Yuzhi JinHui RenQianhua YueWei WuChuan LiuYixuan GuoPeng Zhao

Published in: BMC cancer (2024)

One-year milestone survival outperformed PFS as a SE for OS in HCC, indicating the application of 1-yr survival as a secondary endpoint. In particular, PFS HR was a potential SE for OS HR in the ICI trials.

Keyphrases

free survival
risk assessment
climate change
human health